Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
about
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor RType IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity.New insights into cardiotoxicity caused by chemotherapeutic agents.Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers
P2860
Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
@en
type
label
Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
@en
prefLabel
Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
@en
P2093
P2860
P356
P1476
Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
@en
P2093
Balazs T Nemeth
Wen Jin Wu
Zoltan V Varga
P2860
P356
10.1111/BPH.13643
P407
P50
P577
2016-10-07T00:00:00Z